Brain Tumor & Cancer Treatment Center | Tisch Brain Tumor Center

We provide hope and empower brain tumor patients with unparalleled care, research, and education.

May is Brain Tumor Awareness Month!

To start your care at Duke, contact us at 919-684-5301

Donate to the Brain Tumor Center!

Make a difference & join the fight against brain cancer.

The Preston Robert Tisch Brain Tumor Center operates independently and is not affiliated with any external labs or organizations; for any inquiries, please contact us directly at 919-684-5301.

Angels Among Us

Angels Among Us is a celebration of life, strength, courage, and commitment. It has become a national family event. The first event in 1994 raised $27,000. The 2023 event raised more than $2.2 million—bringing the total to over $36 million to support brain tumor research at The Preston Robert Tisch Brain Tumor Center. Your gifts are used for brain tumor research and education and may be endowed to provide ongoing support.

Stories of Discovery

We are courageously leading the quest to conquer brain cancer!

The Biology of Brain Tumors

FINDING WAYS TO UNDERSTAND BETTER THE BIOLOGY of brain tumors is key to helping scientists develop more targeted treatments and possibly, one day, a cure for brain cancer.

Predicting and Preventing Brain Tumors

PREVENTION COULD MAKE A BIG DIFFERENCE FOR BRAIN CANCER because it continues to evade effective treatments. Kyle Walsh, Ph.D., studies the human genome to help advance the prevention and prediction of cancerous brain tumors.

A Precise Look at Tumor Behavior

THE TISSUE THAT MAKES UP BRAIN TUMORS is very complex. It’s not easy for scientists to look at tumor cells all at once and figure out what’s happening in the tumor. But discovering better, more precise ways to look at these cells and their genetic makeup holds promise for faster diagnoses and better treatments.

Collaborating for Clinical Trial Success

RESEARCHERS AT DUKE HAVE BEEN WORKING for years to harness the power of the body’s immune system to fight brain tumors. Annick Desjardins, MD, FRCPC, says the successes Duke has had so far in developing immunotherapies—treatments that boost the immune system’s ability to kill cancer— are mainly due to strong collaborations.